Model-Based Approach for Designing an Efficient Bioequivalence Study for Highly Variable Drugs

The statistical procedures as outlined by the European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) guidelines for bioequivalence testing of highly variable drugs (HVDs) are complex. Additionally, the sample size is affected by clinical study designs or practical real-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eunjung Song, Woojoo Lee, Bo-Hyung Kim
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/686337b3d33f4425bb72ad40e19399df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!